NCT00641927View on ClinicalTrials.gov

Antidepressant Therapy for Bipolar II Major Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Bipolar Type II Disorder
Interventions
DRUG

Venlafaxine

37.5 mg - 375 mg daily, 12 Weeks

DRUG

Lithium Carbonate

300 mg - 2100 mg daily, 12 weeks

Trial Locations (1)

19104-3309

Depression Research Unit, Department of Psychiatry, University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Stanley Medical Research Institute

OTHER

NCT00641927 - Antidepressant Therapy for Bipolar II Major Depression | Biotech Hunter | Biotech Hunter